Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

ion and Elan discussed its acquisition strategy.
  • 18 February 2013: Royalty Pharma called Elan's Chairman requesting an in-person meeting to discuss the Proposal.
  • 20 February 2013: In-person meeting with Elan's Chairman; offer letter containing the Proposal delivered to Elan's Chairman.
  • 22 February 2013: Elan issued press release reiterating its acquisition strategy, and announcing a US$1 billion share buy-back programme and debt refinancing. Elan failed to disclose that it has received Royalty Pharma's Proposal.
  • 25 February 2013: Royalty Pharma announced the Proposal to acquire Elan for US$11 per Share / ADS; Elan confirms receipt of Proposal and characterizes it as "highly conditional". Royalty Pharma has had no formal response to its Proposal to date.
  • 4 March 2013: Elan announced plan to distribute 20 percent of the Tysabri Royalty to Elan Shareholders through dividends.
  • This week: Royalty Pharma is meeting Elan Shareholders to move towards a recommended transaction.
  • APPENDIX III: Royalty Pharma's track record of raising capital in the debt and equity marketsThe following chronology of recent events is provided as further background to Royalty Pharma's Proposal and representative of its ability to access the debt and equity markets.

  • In November 2012, Royalty Pharma raised a US$705 million senior secured term loan A facility.
  • In October 2012, Royalty Pharma raised US$2,718 million in senior secured term loan facilities.
  • In May 2012, Royalty Pharma raised US$600 million of incremental term loan B debt.
  • In November 2011, Royalty Pharma raised US$345 million in new equity.
  • In August 2011, Royalty Pharma raised a US$2,750 million senior secured term loan B facility due in 2016 and 2018.
  • In August 2011, Royalty Pharma raised a US$850 million senior secured term loan A facility.
  • In July 2011, Royalty Pharma raised a US$400 million add-on t
    '/>"/>

  • SOURCE RP Management, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
    2. Cowen Healthcare Royalty Partners Raises $1 Billion
    3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
    4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    6. AVANIR Pharmaceuticals To participate in two conferences in March
    7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
    8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing ... - Global Version" report to their offering. ... area of molecular diagnostics and pharmacogenics hold the ... market that is moving out of the national ...
    (Date:5/5/2015)... SAN FRANCISCO, Calif. , May 5, 2015 /PRNewswire/ ... the treatment of cancer, today announced that Sean ... at the Credit Suisse Antibody Day in ... Wednesday, May 6. Dr. McCarthy will present an overview ... immunotherapy and Probody drug conjugate programs. About ...
    (Date:5/5/2015)... May 5, 2015   Tocagen Inc. , ... David R. Parkinson , M.D., a venture partner ... to the board of directors of Tocagen. Dr. ... in oncology clinical development, including leading clinical activities ... approvals of the cancer therapeutics Gleevec®, Femara®, Zometa®, ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 GEA ... last week as recipients of the INTERPHEX Exhibitor ... recognition of their Portable, Continuous, Miniature and Modular ... a small footprint, continuous processing equipment, smart control ... process API powders and inactive ingredients into bulk ...
    Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3
    ... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: SCR ... generic,pharmaceuticals and manufacturer of the patented anti-cancer biotech ... announced preliminary revenue,and earnings for the full year ... upon preliminary data for the fourth quarter, Simcere ...
    ... Jan. 9 Human Genome Sciences, Inc. (Nasdaq: ... the 27th Annual JPMorgan Healthcare Conference will be webcast ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )A member of Human Genome Sciences, ... company on Wednesday, January 14, 2009 at 7:30 am ...
    ... Human Bionics Inc., "Victhom" (TSX: VHB), today announced ... www.victhom.com . The Website features a new ... operating divisions; Neurobionix, which is developing an implantable ... is developing and manufacturing computerized prostheses for above-knee ...
    Cached Biology Technology:Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings 2Victhom Announces Launch of Enhanced Company Website 2
    (Date:3/24/2015)... GARDENS, Fla. , March 24, 2015 /PRNewswire/ ... identity management solutions, today announced that its U.are.U ... clothing accessory retailer Goorin Bros . to ... Crossmatch biometrics-based solution secures access to the POS ... the increased risk of data breaches. ...
    (Date:3/23/2015)... , March 23, 2015  In the 2014 ... fraud case conviction losses. This figure accounts for a ... according to The Nilson Report, exceeds $11 billion globally. ... tool after a crime has occurred. Investor Mark ... polygraph expert Joe Paolella partnered to administer ...
    (Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ... - Global Strategic Business Report" report to their offering. ... Geometry in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Rest of World. Annual estimates and forecasts are ...
    Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
    ... Too little of a protein called neogenin results in ... for a more fragile bone framework lifelong, Medical College ... neogenin deficits has poorly defined digits and is generally ... future development, said Dr. Wen-Cheng Xiong, developmental neurobiologist in ...
    ... , COLD SPRING HARBOR, N.Y. (July 27, 2010) -- ... interest in working with medical discovery teams, careers at drug, ... fulfilling. A new book from Cold Spring Harbor Laboratory ... readers to entry-level clinical job opportunities and explains how to ...
    ... Researchers have long envied spiders, ability to manufacture ... as steel or Kevlar. Indeed, finer than human hair, ... times tougher than the top quality man-made fiber Kevlar, ... applications. Suggested industrial applications have ranged from parachute cords ...
    Cached Biology News:Protein identified that can result in fragile bones 2New book describes career opportunities in clinical research and how to qualify for them 2Native-like spider silk produced in metabolically engineered bacterium 2
    ...
    ... The Mini-PROTEAN II multiscreen apparatus is used to ... cm) gels. The apparatus can screen up to ... cut the blot into strips. The apparatus includes ... that accommodate one or two 8 x 7 ...
    Fingerprinting II database sharing tools is an optional module for the Fingerprinting II Basic software package that enables peer-to-peer data exchange over the internet and provides external databas...
    ... II Informatix dimensioning ... optional module that ... analysis, multidimensional scaling, ... MANOVA, and self-organizing ...
    Biology Products: